hamburger menu
All Coursesall course arrow
adda247
reward-icon
adda247
    arrow
    arrow
    arrow
    ​Which one of the following statements about cancers is INCORRECT?​
    Question

    Which one of the following statements about cancers is INCORRECT?

    A.

    The c-myc gene is translocated to one of the immunoglobulin loci in a majority of Burkitt’s lymphomas.

    B.

    Viral integration into the cellular genome may convert a proto-oncogene into an oncogene.

    C.

    The functions of p53 and Rb are augmented by E6 and E7 proteins of human papillomavirus.

    D.

    Many cases of metastatic breast cancer display increased expression of human epidermal-growth-factor-like receptor 2 (HER2).

    Correct option is C

    Explanation-

    ​Option C - The functions of p53 and Rb are augmented by E6 and E7 proteins of human papillomavirus.
    This is factually wrong. The E6 and E7 proteins of HPV do NOT augment p53 and Rb. Instead E6 promotes degradation of p53 and E7 inactivates Rb, releasing E2F and promoting cell cycle progression.
    Thus, these viral proteins inhibit tumor suppressors, contributing to cancer.

    Correct options-

    ​Option A - The c-myc gene is translocated to one of the immunoglobulin loci in a majority of Burkitt's lymphomas.
    This is a well-established fact. In Burkitt's lymphoma, c-myc is commonly translocated to the IgH locus (chromosome 14) or sometimes to IgK (2) or IgL (22). This results in overexpression of c-myc, driving uncontrolled proliferation.
    Option B -  Viral integration into the cellular genome may convert a proto-oncogene into an oncogene.
    This is true. Oncogenic viruses (e.g., HPV, HBV, HTLV) can integrate into host genomes, disrupting regulatory regions or activating proto-oncogenes.
    Example: HPV integration can lead to oncogenesis by affecting host gene expression.
    Option D -  Many cases of metastatic breast cancer display increased expression of human epidermal-growth-factor-like receptor 2 (HER2).
    HER2 is amplified/overexpressed in about 20–30% of breast cancers, especially aggressive/metastatic forms. It is used as a diagnostic and therapeutic target (e.g., trastuzumab/Herceptin).

    Since option C is the only incorrect option among all the other , that makes it a correct answer.

    Similar Questions

    test-prime-package

    Access ‘CSIR NET Life Sciences’ Mock Tests with

    • 60000+ Mocks and Previous Year Papers
    • Unlimited Re-Attempts
    • Personalised Report Card
    • 500% Refund on Final Selection
    • Largest Community
    students-icon
    353k+ students have already unlocked exclusive benefits with Test Prime!
    test-prime-package

    Access ‘CSIR NET Life Sciences’ Mock Tests with

    • 60000+ Mocks and Previous Year Papers
    • Unlimited Re-Attempts
    • Personalised Report Card
    • 500% Refund on Final Selection
    • Largest Community
    students-icon
    353k+ students have already unlocked exclusive benefits with Test Prime!
    Our Plans
    Monthsup-arrow